Skip to content
Screener

Agilon Health AGL Q1 2026 earnings

Reported May 6, 2026 · After market close

Revenue$1.4BBeat by $40.5M
EPS$1.80Beat by $0.67
Revenue estimate$1.4B
EPS estimate$1.13

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$1.5B
EPS estimate-$1.22

Financials

Q1 2026

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$131.26M-92.6%
Enterprise value-$46.9M-103%
P/S0×-0.3×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%—

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio1×-0.2×

Segments

By product

See full
Medical services revenue$1.4B-7.3%

FAQ

When did Agilon Health report Q1 2026 earnings?
Agilon Health (AGL) reported Q1 2026 earnings on May 6, 2026 after market close.
What were Agilon Health's Q1 2026 revenue and EPS?
Agilon Health reported revenue of $1.4B and eps of $1.80 for Q1 2026.
Did Agilon Health beat estimates in Q1 2026?
Revenue beat the consensus estimate of $1.4B by $40.5M. EPS beat the consensus estimate of $1.13 by $0.67.
How did Agilon Health's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 7.3% from $1.5B a year earlier and eps grew 6037.1% from $0.03.
Where can I find Agilon Health's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-031254) and the 10-Q periodic report (0001628280-26-031270) directly on SEC EDGAR. The filing index links above go to sec.gov.